Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 46, Status: Authorised

Human medicines European public assessment report (EPAR): Wegovy, semaglutide, Date of authorisation: 06/01/2022, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Pregabalin Zentiva, pregabalin, Date of authorisation: 17/07/2015, Revision: 18, Status: Authorised

Shoulder prostheses - Notified body 0459 - 25/08/2022 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

Medical device expert panels

High-risk medical devices: consultation procedures and advice

Class III implantable devices and Class IIb medical devices intended to administer or remove medicinal products: expert panel opinions

Class D in vitro diagnostic devices: expert panel views

Medical devices: expert panel advice at the request of the Medical Device Coordination Group and the European Commission